|
The Yost
Legal Group is currently handling cases of persons who may have been
injured as a result of taking phenylpropanolamine (PPA). Our staff has
extensive experience in litigation involving fen-phen, Rezulin, Propulsid,
Ephedra and other toxic medications. We can help you determine whether you
or your loved one has a claim against the manufacturers of drugs
containing phenylpropanolamine (PPA).
Currently,the Food and Drug Administration
(FDA) is taking steps to remove phenylpropanolamine (PPA) from all drug
products and has requested that all drug companies discontinue marketing
products containing PPA. In addition, FDA has issued a public health
advisory concerning phenylpropanolamine hydrochloride. This drug is an
ingredient used in many over-the-counter (OTC) and prescription cough and
cold medications as a decongestant and in OTC weight loss products.
Scientists at Yale University School of Medicine recently issued a
report entitled "Phenylpropanolamine
& Risk of Hemorrhagic Stroke: Final Report of the
Hemorrhagic Stroke Project."
This study reports that taking PPA increases the risk of
hemorrhagic stroke (bleeding into the brain or into tissue
surrounding the brain) in women. Men may also be at
risk. Although the risk of hemorrhagic stroke is
very low, FDA recommends that consumers not use any
products that contain PPA.
FDA’s Nonprescription Drugs Advisory Committee recently
discussed this study and other information on
phenylpropanolamine. The Committee determined that
there is an association between PPA and hemorrhagic stroke
and recommended that PPA not be considered safe for
over-the-counter use.
For more information on this public health advisory, please
see the items below.
If you or a loved one has
suffered a stroke or believes to have been injured by taking a drug
containing PPA please contact our offices immediately.
|
